Cryosite Limited (ASX:CTE)
Australia flag Australia · Delayed Price · Currency is AUD
0.8000
0.00 (0.00%)
Aug 27, 2025, 10:15 AM AEST

Cryosite Company Description

Cryosite Limited provides outsourced clinical trials logistic services in Australia.

It operates through Ambient, cold, and frozen, Ultra-frozen and cryogenic, and Cord Blood segments. The Ambient, cold, and frozen segment provides good manufacturing practice (GMP) clinical trial materials, scheduled medicines, controlled drug storage, clinical ancillary supplies, medical devices, and commercial products with strict temperature requirements.

The Ultra-frozen and cryogenic segment offers advanced therapy medicinal products (ATMPS), such as cell and gene therapies (CGT), cell therapies, mRNA-based medicines, biological samples, and research and development materials requiring high-integrity cold storage.

The Cord Blood segment provides storage of cord blood cell and tissue samples for personal or directed therapeutic use by maintaining under validated chain-of-identity controls.

It also, offers reverse logistics services, secondary packaging, and quality transportation and distribution solutions.

Cryosite Limited was incorporated in 1999 and is based in South Granville, Australia.

Cryosite Limited
CountryAustralia
Founded1999
IndustryDiagnostics & Research
SectorHealthcare
Employees25

Contact Details

Address:
13a Ferndell Street
South Granville, New South Wales 2142
Australia
Phone61 2 8865 2000
Websitecryosite.com

Stock Details

Ticker SymbolCTE
ExchangeAustralian Securities Exchange
Fiscal YearJuly - June
Reporting CurrencyAUD
ISIN NumberAU000000CTE1
SIC Code8090

Key Executives

NamePosition
Jane HaoChief Financial Officer
Hamish GeorgeCompany Secretary